Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer
Cancer Cell International · 09.07.2024 · 24 (1)
DOI: 10.1186/s12935-024-03418-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell International, online erschienen am 09.07.2024. Verfasst von Wei Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue, Jianghan Distr…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
In tumor treatment, protein tyrosine kinase inhibitors (TKIs) have been extensively utilized. However, the efficacy of TKI is significantly compromised by drug resistance. Consequently, finding an effective solution to overcome TKI resistance becomes crucial. Reactive oxygen species (ROS) are a group of highly active molecules that play important roles in targeted cancer therapy including TKI targeted therapy. In this review, we concentrate on the ROS-associated mechanisms of TKI lethality in tumors and strategies for regulating ROS to reverse TKI resistance in cancer. Main body Elevated ROS levels often manifest during TKI therapy in cancers, potentially causing organelle damage and cell death, which are critical to the success of TKIs in eradicating cancer cells. However, it is noteworthy that cancer cells might initiate resistance pathways to shield themselves from ROS-induced damage, leading to TKI resistance. Addressing this challenge involves blocking these resistance pathways, for instance, the NRF2-KEAP1 axis and protective autophagy, to promote ROS accumulation in cells, thereby resensitizing drug-resistant cancer cells to TKIs. Additional effective approaches inducing ROS generation within drug-resistant cells and providing exogenous ROS stimulation.
Conclusion
ROS play pivotal roles in the eradication of tumor cells by TKI. Harnessing the accumulation of ROS to overcome TKI resistance is an effective and widely applicable approach. Graphical Abstract
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue, Jianghan District, Wuhan, Hubei, 430022, P.R. China.
- Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Cardiothoracic Surgery, Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan, China.
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue, Jianghan District, Wuhan, Hubei, 430022, P.R. China. liaoyongde@hust.edu.cn.
- Department of Internal Medicine, Renmin Hospital, Wuhan University, Wuhan, 430022, China. longqh666@163.com.
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue, Jianghan District, Wuhan, Hubei, 430022, P.R. China. 15613523559@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lin, W., Wang, X., Diao, M., Wang, Y., Zhao, R., Chen, J., Liao, Y., Long, Q., & Meng, Y. (2024). Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer. Cancer Cell International, 24(1). https://doi.org/10.1186/s12935-024-03418-x
Vancouver
Lin W, Wang X, Diao M, Wang Y, Zhao R, Chen J, et al. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer. Cancer Cell International. 2024;24(1). doi:10.1186/s12935-024-03418-x
BibTeX
@article{Lin2024,
author = {Lin, Wei and Wang, Xiaojun and Diao, Mingxin and Wang, Yangwei and Zhao, Rong and Chen, Jiaping and Liao, Yongde and Long, Qinghong and Meng, Yunchong},
title = {Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer},
journal = {Cancer Cell International},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12935-024-03418-x}
}
EUVIMED